The Struggle to End a Millennia-Long Pandemic: Novel Candidate and Repurposed Drugs for the Treatment of Tuberculosis Brett D. EdwardsStephen K. Field Review Article 07 December 2022 Pages: 1695 - 1715
Risk of Erectile Dysfunction in Male Patients with Gout Treated with Febuxostat or Allopurinol: A Propensity Score-Matched Cohort Study Qiang TongYu DuSheng-Ming Dai Original Research Article 07 December 2022 Pages: 1717 - 1726
Pegcetacoplan: A Review in Paroxysmal Nocturnal Haemoglobinuria Young-A Heo Adis Drug Evaluation Open access 02 December 2022 Pages: 1727 - 1735
Comment on: “Global Consumption Trend of Antifungal Agents in Humans from 2008 to 2018: Data from 65 Middle‐ and High‐Income Countries” David W. Denning Letter to the Editor 01 December 2022 Pages: 1751 - 1753
Authors’ Reply to Denning: Comment on: “Global Consumption Trend of Antifungal Agents in Humans From 2008 to 2018: Data From 65 Middle- and High-Income Countries” Swathi PathadkaVincent K. C. YanEsther W. Chan Letter to the Editor 01 December 2022 Pages: 1755 - 1756
Correction: Teprotumumab: A Review in Thyroid Eye Disease Tina NieYvette N. Lamb Correction Open access 02 December 2022 Pages: 1757 - 1757
